Clinical characterization and obstetrical outcomes of pregnant women with SARS-CoV-2 infection

  • Funded by The Structural Genomics Consortium (SGC)
  • Total publications:4 publications

Grant number: C-0032

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    The Structural Genomics Consortium (SGC)
  • Principal Investigator

    Xingfei Pan, Jutta Schroeder-Braunstein
  • Research Location

    China, Germany
  • Lead Research Institution

    Third Affiliated Hospital of Guangzhou Medical University, University Hospital Heidelberg
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

Publicationslinked via Europe PMC

Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum.

IL-6 drives T cell death to participate in lymphopenia in COVID-19.

Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health.